The Sunday Times’ tech correspondent Danny Fortson brings on David Stein, chief executive of Babson Diagnostics, to talk about the importance of blood testing (4:49), why Babson is not Theranos (6:47), trying to compete with that idea (9:26), why they succeeded where Theranos failed (14:34), using a tiny amount of blood (18:23), fighting against the Theranos effect (24:37), being owned by a company they aim to disrupt (26:28), liquid biopsies (28:02), the new age of biological data (32:23), regulatory approval (37:09), and avoiding the spotlight (39:03).<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>

The Times Tech Podcast

Babson’s David Stein: “Succeeding where Theranos failed”

As The Sunday Times’ West Coast Correspondent, Danny Fortson has witnessed the technological whirlwind coming from Silicon Valley first hand. The Times' Technology Business Editor Katie Prescott has reported on how digital technology is transforming businesses and society around the world. Now, 'Danny in the Valley' meets 'Katie in the City', with a podcast presented from San Francisco and London. Each week sees a fresh interview with pioneers in tech, from the brightest start-ups to the tech giants, as Katie and Danny chronicle the AI revolution. Hosted on Acast. See acast.com/privacy for more information.